Bristol Myers Squibb has announced updates to its conditions on pharmaceutical sales involving contract pharmacies.
News Alert
BMS Expands 340B Contract Pharmacy Conditions, Including for Grantees
Views
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, effective Nov. 1. BMS outlined [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.